Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia - via Blood Journal. First author Robert Le, last author R. Angelo De Claro. sciencedirect.com/science/articl…
#OCEPublications

Laura Crandon will also serve as a panelist at the June #ConversationsonCancer . She is the founder of Touch4Life, a nonprofit dedicated to eradicating disparities in cancer outcomes. From her battle with breast cancer, she turned her pain into purpose.
surveymonkey.com/r/SKJGDZD

Attending #ASCO24 ? FDA Oncology experts will be speaking ASCO Annual Meeting May 31-June 4 in Chicago. Add these talks to your calendar! fda.gov/about-fda/onco…

#OCETalks

Tomorrow, May 22, the FDA ODAC Pediatric Oncology Subcommittee meets to discuss implementation and impact of the RACE for Children Act on drug development for pediatric patients with cancer, with speakers from EMA, academia, and industry.
fda.gov/advisory-commi…

Charlene Le Fauve is one of our panelists for the June 13 #ConversationsOnCancer . With a 31-year career in behavioral health and addiction research, she currently serves as the leading authority on advancing health equity for tobacco products FDA Tobacco.
surveymonkey.com/r/SKJGDZD

Participate in our next #ConversationsonCancer on June 13, coinciding with
the start of National Black Family Cancer Awareness Week. The theme, “Engaging the Generations” is a call to action against cancer. #BlackFamCan #OCEProjectCommunity
surveymonkey.com/r/SKJGDZD

你知道吗？有一些检查可以在出现任何体征或症状之前及早发现某些癌症。请向你的医疗服务提供者咨询癌症筛查是否适合你。在以下网站查看这些可用资源：Project ASIATICA | FDA。
fda.gov/about-fda/onco…

On May 22, FDA will hold a virtual meeting of the ODAC Pediatric Oncology Subcommittee to discuss implementation and impact of the RACE for Children Act on drug development for pediatric patients with cancer, with speakers from EMA, academia, and industry.
fda.gov/advisory-commi…

Today, the FDA Oncology Center of Excellence announced The OCE Equity Program. This program expands the Center’s work to improve access to cancer clinical trials for populations historically underrepresented in clinical research. fda.gov/about-fda/onco…
#OCEEquityProgram

Brenda Adjei, Ed.D., will serve as a panelist for the June 13 #ConversationsOnCancer and is the Associate Director for Healthcare Delivery and Equity Research in the Office of the Clinical Director NCI Center for Cancer Research. #BlackFamCan

surveymonkey.com/r/SKJGDZD

FDA Oncology Center Project 5 in 5 crowdsourcing initiative is seeking 5 clinically relevant questions for 5 pragmatic clinical trials, using FDA-approved therapies!
💡 Got any ideas? Sign up and submit ideas here ⤵️ shareyourvoice.ideascalegov.com/c/

#OCEProject5in5 #PragmaticTrials

An oncologist doesn't have to be a researcher or belong to a research institution to use Expanded access for their patients with cancer. OCE's Project Facilitate call center aims to assist health care providers throughout the process.
fda.gov/about-fda/onco…

#ProjectFacilitate

Complete Remission with Partial Hematological Recovery as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia - via Blood Journal. First author Robert Le, last author R. Angelo De Claro. sciencedirect.com/science/articl…
#OCEPublications

Alam mo ba na ang mga pagsubok ay maaaring matuklasan ang ilang mga kanser maaga, bago ka magkaroon ng anumang mga tanda o sintomas? Pakikipag-usap sa iyong provider ng kalusugan tungkol sa kung ang pag-screening para sa kanser ay tamang para sa iyo.
fda.gov/about-fda/onco…

The FDA Oncology Regulatory Affairs and Policy Program collaborates with CDER, CBER, and CDRH to develop and execute an integrated regulatory approach to enhance the cross-center coordination of oncology product clinical review. fda.gov/about-fda/onco…

On May 22, FDA will hold a virtual meeting of the ODAC Pediatric Oncology Subcommittee to discuss implementation and impact of the RACE for Children Act on drug development for pediatric patients with cancer, with speakers from EMA, academia, and industry.
fda.gov/advisory-commi…